palladium has been researched along with Cancer of Ovary in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belluti, S; Costi, MP; D'Arca, D; Gozzi, G; Imbriano, C; Lauriola, A; Marverti, G; Ponterini, G | 1 |
| Bortolamiol, E; Caligiuri, I; Canzonieri, V; Demitri, N; Palazzolo, S; Perin, T; Rizzolio, F; Scattolin, T; Togni, A; Visentin, F | 1 |
| Caligiuri, I; Canovese, L; Demitri, N; Gambari, R; Lampronti, I; Rizzolio, F; Santo, C; Scattolin, T; Visentin, F | 1 |
| Batista de Carvalho, LA; Clark, K; Diegelman, P; Fiuza, SM; Kramer, DL; Marques, MP; Pendyala, L; Porter, CW; Tummala, R; Vujcic, S | 1 |
| Kazhdan, I; Motley, DM; Polyanskaya, TV; Walmsley, JA | 1 |
| Beale, P; Chan, C; Huq, F; Mazumder, ME; Yu, JQ | 2 |
| Beale, P; Daghriri, H; Huq, F | 1 |
| Fernández-Botello, A; García-Friaza, G; Moreno, V; Pérez, JM; Prieto, MJ | 1 |
| Casas, JS; Castellano, EE; Ellena, J; García-Tasende, MS; Pérez-Parallé, ML; Sánchez, A; Sánchez-González, A; Sordo, J; Touceda, A | 1 |
10 other study(ies) available for palladium and Cancer of Ovary
| Article | Year |
|---|---|
The 1,10-Phenanthroline Ligand Enhances the Antiproliferative Activity of DNA-Intercalating Thiourea-Pd(II) and -Pt(II) Complexes Against Cisplatin-Sensitive and -Resistant Human Ovarian Cancer Cell Lines.
Topics: Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cisplatin; Coordination Complexes; DNA; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Female; Humans; Intercalating Agents; Ligands; Ovarian Neoplasms; Palladium; Phenanthrolines; Platinum; Thiourea | 2019 |
Palladium(II)-η
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Coordination Complexes; Female; Humans; Ligands; Ovarian Neoplasms; Palladium | 2020 |
Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activities on human ovarian cancer cell lines.
Topics: Alkenes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Female; Heterocyclic Compounds; Humans; Inhibitory Concentration 50; Ligands; Methane; Organometallic Compounds; Ovarian Neoplasms; Palladium; Purines | 2018 |
Characterization of Pt-, Pd-spermine complexes for their effect on polyamine pathway and cisplatin resistance in A2780 ovarian carcinoma cells.
Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cisplatin; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Macromolecular Substances; Metabolic Networks and Pathways; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Palladium; Platinum Compounds; Polyamines; Spermine | 2010 |
Synthesis, characterization and cytotoxicity studies of palladium(II)-proflavine complexes.
Topics: Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Ovarian Neoplasms; Palladium; Proflavine; Solutions; Spectrometry, Mass, Electrospray Ionization | 2010 |
Synthesis and cytotoxicity of three trans-palladium complexes containing planaramine ligands in human ovarian tumor models.
Topics: Amines; Cell Line; Cell Survival; Cisplatin; Coordination Complexes; DNA; Drug Resistance, Neoplasm; Female; Humans; Isomerism; Ligands; Ovarian Neoplasms; Palladium | 2012 |
Epigallocatechin gallate acts synergistically in combination with cisplatin and designed trans-palladiums in ovarian cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; DNA Adducts; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Palladium | 2012 |
Studies on activities, cell up take and DNA binding of four multinuclear complexes of the form: [[trans-PtCl(NH(3))(2)](2)mu-[trans-Pd(NH(3))(2)-(H(2)N(CH(2))(n)NH(2))(2)]]Cl(4) where n=4-7.
Topics: Antineoplastic Agents; Binding Sites; Biological Transport; Cell Line, Tumor; Cell Survival; DNA, Neoplasm; Female; Humans; Kinetics; Ovarian Neoplasms; Palladium; Plasmids; Platinum Compounds; Restriction Mapping | 2004 |
Synthesis and characterization of palladium(II) and platinum(II) complexes with Schiff bases derivatives of 2-pyridincarboxyaldehyde. Study of their interaction with DNA.
Topics: Aldehydes; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; DNA; DNA Adducts; Female; Humans; Inhibitory Concentration 50; Mass Spectrometry; Microscopy, Atomic Force; Molecular Structure; Organic Chemicals; Ovarian Neoplasms; Palladium; Platinum; Pyridines; Schiff Bases | 2006 |
New Pd(II) and Pt(II) complexes with N,S-chelated pyrazolonate ligands: molecular and supramolecular structure and preliminary study of their in vitro antitumoral activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Female; Humans; Hydrogen Bonding; Molecular Structure; Organoplatinum Compounds; Ovarian Neoplasms; Palladium; Pyrazolones; X-Ray Diffraction | 2008 |